Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria

Karen D Weynberg1,2, Paul R Jaschke3

  • 1School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Australia.

PHAGE (New Rochelle, N.Y.)
|September 23, 2022
PubMed

Insights

Antibiotic resistance is a global crisis. Synthetic biology can enhance bacteriophage (phage) therapy to combat multidrug-resistant bacteria, with biofoundries playing a key role in its development.

Area of Science:

  • Microbiology
  • Synthetic Biology
  • Biotechnology

Background:

  • Antibiotic resistance poses a significant global health threat.
  • Phage therapy, using bacteriophages to kill bacteria, is an alternative treatment.
  • Phage specificity limits their effectiveness against diverse bacterial strains.

Purpose of the Study:

  • To explore synthetic biology's potential for enhancing phage therapeutics.
  • To discuss the role of biofoundries in advancing phage therapy.

Main Methods:

  • The article is a perspective piece, discussing existing and potential applications.
  • It reviews the principles of synthetic biology in phage engineering.
  • It highlights the capabilities of biofoundries for scalable phage production and modification.

Main Results:

  • Synthetic biology offers tools to engineer phages with broader host ranges and improved efficacy.
  • Biofoundries can accelerate the development and deployment of customized phage therapies.
  • This approach can overcome limitations of natural phage infectivity.

Conclusions:

  • Synthetic biology presents a promising avenue to enhance phage therapy against multidrug-resistant pathogens.
  • Biofoundries are crucial for the industrialization and clinical translation of engineered phage therapeutics.
  • This innovative strategy could provide a vital solution to the antibiotic resistance crisis.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.6K
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
179
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
104
Antibiotic Selection00:57

Antibiotic Selection

Overview
55.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
129